candesartan has been researched along with losartan potassium in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furukawa, Y; Imamiya, E; Inada, Y; Kohara, Y; Kubo, K; Naka, T; Nishikawa, K; Sugiura, Y | 1 |
Schieffer, B; Schmidt, B | 1 |
Achard, JM; Black, SE; Fournier, A; Oprisiu, R; Serot, JM | 1 |
1 review(s) available for candesartan and losartan potassium
Article | Year |
---|---|
Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Growth Hormone; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Models, Molecular; Receptor, Angiotensin, Type 1; Tetrazoles; Thiophenes; Thromboxane A2 | 2003 |
2 other study(ies) available for candesartan and losartan potassium
Article | Year |
---|---|
Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids.
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Binding Sites; Blood Pressure; Muscle, Smooth, Vascular; Rabbits; Rats; Rats, Inbred SHR; Structure-Activity Relationship; Tetrazoles | 1993 |
Treating stroke in the 21st century.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Erythropoietin; Humans; Randomized Controlled Trials as Topic; Stroke; Tetrazoles | 2007 |